Serum angiopoietin-2 as a clinical marker for lung cancer.
about
A novel angiopoietin-2 selective fully human antibody with potent anti-tumoral and anti-angiogenic efficacy and superior side effect profile compared to Pan-Angiopoietin-1/-2 inhibitors.Angiogenesis-related biomarkers in patients with alcoholic liver disease: their association with liver disease complications and outcome.Angiopoietin-2: development of inhibitors for cancer therapy.Identification of serum angiopoietin-2 as a biomarker for clinical outcome of colorectal cancer patients treated with bevacizumab-containing therapyAssociation of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancerCirculating Ang-2 mRNA expression levels: looking ahead to a new prognostic factor for NSCLC [corrected]Serum vascular endothelial growth factor and angiopoietin-2 are associated with the severity of systemic inflammation rather than the presence of hemoptysis in patients with inflammatory lung disease.Why targeted therapy hasn't worked in advanced cancer.Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis.Evaluation of serum and pleural levels of angiopoietin-1 and angiopoietin-2 in children with transudative and exudative pleural effusions.Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastoma.Serum biomarkers of papillary thyroid cancerEvaluation of Angiopoietin-2 as a biomarker in gastric cancer: results from the randomised phase III AVAGAST trial.Plasma angiopoietin-2 is persistently elevated after non-small cell lung cancer surgery and stimulates angiogenesis in vitro.Bench-to-bedside review: Angiopoietin signalling in critical illness - a future target?Blood vessel maturation, vascular phenotype and angiogenic potential in malignant melanoma: one step forward for overcoming anti-angiogenic drug resistance?Targeting angiopoietin-2 signaling in cancer therapy.Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference.Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers.Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancerAngiopoietin pathway gene expression associated with poor breast cancer survival.Anti-angiogenesis by lentivirus-mediated small interfering RNA silencing of angiopoietin-2 gene in pancreatic carcinoma.Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.The role of serum angiopoietin-2 levels in progression and prognosis of lung cancer: A meta-analysis.Time-dependent changes of plasma concentrations of angiopoietins, vascular endothelial growth factor, and soluble forms of their receptors in nonsmall cell lung cancer patients following surgical resection.Circulating angiopoietin-2, its soluble receptor Tie-2, and mortality in the general population.Angiopoietin 2 levels in serum and bronchial lavage fluids and their relationship with cancer stages in lung cancer patients.Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy.MicroRNA-542-3p inhibits tumour angiogenesis by targeting angiopoietin-2.Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain.Bloch surface wave enhanced biosensor for the direct detection of Angiopoietin-2 tumor biomarker in human plasma.Prognostic value of pro-inflammatory cytokine and pro-angiogenesis factor in differentiating malignant from benign exudative effusion.VEGF-D and A Preoperative Serum Levels Predict Nodal and Distant Metastases in Differentiated Thyroid Cancer Patients.Vascular endothelial growth factors and angiopoietins in presentations and prognosis of papillary thyroid carcinoma.[The influence of inhibiting angiopoietin-2 on the biological characteristics of bronchogenic adenocarcinoma].Angiogenic miRNAs, the angiopoietin axis and related TIE2-expressing monocytes affect outcomes in cholangiocarcinoma
P2860
Q31110832-4C55BF0C-29D7-46A2-AE88-8C55D8DB77F8Q33736254-AD925975-B6C8-4DD3-89DE-BD10B5797E43Q33839423-22721FA4-F873-40D3-AF8E-ACA67733C03BQ34344165-12D77BFF-3A36-4824-9560-1A8C3D148478Q34577576-B4CC144B-6E7A-456D-9F65-2EED502363CAQ35108561-CAA6F557-0016-4383-BE2A-90E0785A1CF0Q35767455-3FB04AC3-1B14-4E6F-87A8-6D5B7D5A8DEFQ36014536-A737C686-CD9F-4FFB-98BA-D941675066B4Q36121903-25BEFE89-595D-41B3-B3E9-DDBCD034447AQ36244857-BC456202-0084-4F05-B69E-18763B93B8B5Q36477818-D7B15F04-B533-426C-810D-190B293CC0D7Q36834893-324DBEA8-B06A-45FC-B17A-88C7F86988E6Q37174690-038FF709-616D-46EB-AF60-A8C941FF3D89Q37175995-A36EC866-C346-4004-8D33-C84E64EA6824Q37478709-C88D6565-A2F0-42AE-B923-4E04778D1BC1Q37846342-31947D4B-E507-4969-BD6B-9EB2BEA1CF52Q38101997-928A44D5-738F-4B18-81ED-4A0B1F438A9DQ38259982-A076A86D-CCC2-4496-92F0-81A68B6A7AA7Q38943409-67A517EB-2C55-4CAD-9A70-1DE3D071DD6FQ38982959-49978E03-88D8-4250-A598-27CFDFC0B05EQ39034717-694B82C6-00A8-4AF7-AAF6-E9DE6537BA18Q39512686-950CD1C8-9C22-41D5-8AAE-A13F030C7698Q39824985-EFE889D4-4FBF-4C63-94C2-533A175F525FQ42111598-CDCB373F-2B59-48F2-807A-6B4E0DACDD2EQ42548913-97C0D891-6B6F-441C-B1F0-998EE2FE1C41Q46211892-23384375-D0E1-4015-9B12-C5A681C0EB3BQ50050101-77550DA6-E51F-4269-B553-152DB5F40489Q51739600-6EDD16A3-BE2B-4012-81EA-7D72577277BCQ51760093-A6B04573-1BC7-4C1E-9884-19214E1F2450Q52646854-35D0D75E-7CA4-4951-8EB6-34DD45EEE408Q52649539-2F7D29A1-0DDD-430A-9823-8C539054FB27Q53804643-6BDB26AF-C8D9-4795-8818-04FEB5541F32Q54291391-87EA9FC4-B03D-40FF-B4C4-46B566811E5BQ54604716-7E694953-7693-4036-9660-0E411CA17B9CQ55444655-F93A77E1-1B6B-4928-8636-B37DF2A7B431Q56956744-C19C688C-49AE-4739-A40F-50F12530AB92
P2860
Serum angiopoietin-2 as a clinical marker for lung cancer.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Serum angiopoietin-2 as a clinical marker for lung cancer.
@en
Serum angiopoietin-2 as a clinical marker for lung cancer.
@nl
type
label
Serum angiopoietin-2 as a clinical marker for lung cancer.
@en
Serum angiopoietin-2 as a clinical marker for lung cancer.
@nl
prefLabel
Serum angiopoietin-2 as a clinical marker for lung cancer.
@en
Serum angiopoietin-2 as a clinical marker for lung cancer.
@nl
P2093
P356
P1433
P1476
Serum angiopoietin-2 as a clinical marker for lung cancer.
@en
P2093
Hyoung No Lee
Joo Hun Park
Keu Sung Lee
Kwang Joo Park
Seung Soo Sheen
Yoon Jung Oh
Young Sun Kim
P304
P356
10.1378/CHEST.06-2915
P407
P577
2007-05-15T00:00:00Z